Fresenius SE & Co. KGaA (FRE.DE)
48.81 EUR +0.47%
Fresenius SE & Co. KGaA rose 0.47% in the latest session, at 48.81 EUR. By market cap it is number 4 of the 6 health care stocks on the DAX 40 heatmap. Its trailing P/E of 17.6 is below the median of those peers (24.3). The price is 7.8% below its 52-week high.
Key numbers
- Price
- 48.81 EUR
- Day change
- +0.47% (0.23)
- Market cap
- 27.5B EUR
- P/E (trailing)
- 17.6
- P/E (forward)
- 12.4
- Dividend yield
- 2.20%
- 50-day average
- 45.05
- 200-day average
- 44.06
- 52-week range
- 35.11 – 52.96
- Next earnings
- 4 Nov 2026
- Dividend per share (annual)
- 1.05 EUR
Data as of 3 Nov 2026, 17:35 CET. Market data may be delayed.
Fresenius SE & Co. KGaA over the past year
From daily closing prices. The highest close in the period was 52.12 EUR on 17 Feb 2026, the lowest 35.45 EUR on 1 Jun 2026.
| 1 month | 3 months | 6 months | Year to date | 1 year |
|---|---|---|---|---|
| +11.95% | +10.12% | +23.86% | -0.27% | +0.68% |
| Month | Close (EUR) | Change |
|---|---|---|
| November 2026 | 48.85 | +2.21% |
| October 2026 | 47.79 | +6.80% |
| September 2026 | 44.75 | -1.09% |
| August 2026 | 45.24 | +1.63% |
| July 2026 | 44.52 | +11.38% |
| June 2026 | 39.97 | +10.20% |
| May 2026 | 36.27 | -12.07% |
| April 2026 | 41.25 | -6.93% |
| March 2026 | 44.32 | -12.93% |
| February 2026 | 50.90 | +7.82% |
| January 2026 | 47.21 | -3.61% |
| December 2025 | 48.98 | +3.49% |
Health care peers
Fresenius SE & Co. KGaA is on the DAX 40 heatmap (Health care). How it compares with the other health care stocks there, by market cap:
| Company | Today | Market cap | P/E |
|---|---|---|---|
| Merck KGaA MRK.DE | -0.57% | 64.8B EUR | 27.4 |
| Bayer Aktiengesellschaft BAYN.DE | +3.64% | 50.9B EUR | — |
| Siemens Healthineers AG SHL.DE | -0.12% | 48.5B EUR | 22.0 |
| Fresenius SE & Co. KGaA FRE.DE | +0.47% | 27.5B EUR | 17.6 |
| Fresenius Medical Care AG FME.DE | -3.60% | 10.5B EUR | 11.8 |
| Qiagen N.V. QIA.DE | +0.04% | 9.3B EUR | 26.6 |
More on FRE
Open FRE.DE in zysk for the live chart, news, earnings and dividends, and ask the AI why it moved: it answers in a few lines with sources and a chart (how zysk's AI stock research works). zysk explains facts, news and risks; it is not investment advice.